文献速递新生儿儿童感染

母亲使用卡痛导致新生儿戒断综合征

Neonatal Abstinence Syndrome Due to Maternal Kratom Use.
PubMed 文献 · Pediatrics · 2018-11-07

本文报道一例因母亲每日饮用卡痛茶自我治疗阿片依赖而出现新生儿戒断综合征(NAS)的婴儿。尽管卡痛被营销为非阿片类戒断替代品,但其是否应归类为阿片存在争议。儿科医生和家长应知晓孕期使用卡痛可能导致NAS的风险。

要点

  • 母亲每日饮用卡痛茶自我治疗阿片依赖,其婴儿出现新生儿戒断综合征。
  • 卡痛是否应归类为阿片存在争议,但美国FDA已就此争议表态。
  • 儿科医生和家长应知晓孕期使用卡痛可能导致NAS的风险。

核心结论

  • 孕期使用卡痛可能导致新生儿戒断综合征,应引起儿科医生和家长重视。

研究设计与样本

  • 本文为病例报告,描述一例因母亲每日饮用卡痛茶自我治疗阿片依赖而出现NAS的婴儿。

主要发现

  • 一例婴儿因母亲每日饮用卡痛茶自我治疗阿片依赖而出现新生儿戒断综合征。

临床怎么用

  • 儿科医生和家长应知晓孕期使用卡痛可能导致新生儿戒断综合征的风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neonatal abstinence syndrome (NAS) is increasing in incidence and most commonly associated with maternal opioid use during pregnancy. Nonopioid alternatives to treat opioid dependence are highly sought after in the country's current opioid epidemic. Whether Kratom, a legal, widely available herbal supplement, should be classified as an opioid is contentious. Although the US Food and Drug Administration has recently addressed this controversy, Kratom continues to be marketed as a nonopioid remedy for opioid withdrawal. Its use is increasing in the United States. We describe an infant with NAS born to a mother with daily Kratom tea ingestion to self-treat opioid dependence. Pediatricians and parents should be aware of the risk of NAS due to Kratom use during pregnancy.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Eldridge WB, Foster C, Wyble L, et al. Neonatal Abstinence Syndrome Due to Maternal Kratom Use. Pediatrics. 2018. PMID: 30404789. doi:10.1542/peds.2018-1839

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。